Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7687
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Digoxin-like immunoreactivity in early infant death
Author: Couper, R.
Aldis, J.
Byard, R.
Citation: Medicine Science and the Law, 1998; 38(1):52-56
Publisher: CHILTERN PUBLISHING
Issue Date: 1998
ISSN: 0025-8024
2042-1818
Abstract: The aim of this study was to determine if the level of digoxin-like immunoreactivity in post-mortem sera obtained from infants differs according to the cause of death and if the level is related to age, post-mortem interval, cardiac pathology or adrenal weight. Twelve infants whose deaths were attributed to sudden infant death syndrome (SIDS), and 11 infants who died from other causes, had blood sampled between 3 to 53 hours post-mortem from their right atrial cavity. Digoxin-like immunoreactivity was measured, using a specific and sensitive digoxin radioimmunoassay, and was detected in 7 of the infants who died of SIDS and 7 of those who died from other causes. The highest levels were seen in two patients who died from meningococcal sepsis and haemorrhage, hyperpyrexia and encephalopathy syndrome, respectively. No correlation was detected between the digoxin-like immunoreactivity level, gender, age at death, post-mortem interval or cardiac pathology. Digoxin-like immunoreactivity levels correlated with adrenal weight. It is concluded that digoxin-like immunoreactivity is frequently found in infant sera, but levels are not specific to and are no higher in SIDS infants than infants dying of other conditions.
Keywords: Humans
Sudden Infant Death
Cardenolides
Digoxin
Saponins
Enzyme Inhibitors
Linear Models
Case-Control Studies
Infant
Female
Male
Sodium-Potassium-Exchanging ATPase
DOI: 10.1177/002580249803800108
Published version: http://dx.doi.org/10.1177/002580249803800108
Appears in Collections:Aurora harvest 4
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.